Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall ZEE Aspirin 325mg - 24 tablets in single dose packets, OTC Incorrect/Undeclared Excipients: ZEE Medical is recalling ZEE Aspirin due to the incorrect listing of inactive ingredients on the product label. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ciprofloxacin 500 mg tablets, 20 count bottle Presence of Foreign Tablets/Capsules: Tramodol 50 mg tablet has been found in a bottle of Ciprofloxacin 500 mg Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 8 states named PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNationwide, and Alabama, Florida, Indiana, Mississippi, South Carolina, Virginia, Washington and West Virginia named
- Medicine recall MethylPREDNISolone Tablets, USP, 4 mg, 100 unit dose blisters Subpotent; 6 month stability time point Class IIIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 29, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Hydromorphone Hydrochloride Injection, USP, 10 mg/mL Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall alcosulph Moisturizing Cream, Net Contents: 60g Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall alcosulph Astringent Lotion, Net Contents: 1) 60 mL and 2) 120 mL Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall MUSTARCREME, Net Contents: 60g Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall Ferrol EXPECTORANT, Net Contents: 100 mL Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall WHITFIELD LOTION, Net Contents: 60 mL Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall Whitfield’s OINTMENT B.P., Net Contents: 15g Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall Rector’s Remedy OINTMENT, Net Contents: 15g Does Not Meet Monograph: NEW GPC INC. Class IIFDA’s classOct 29, 2014in FDA’s Enforcement ReportNew Yorkthe one state its words name PublishedOct 29, 2014ClassClass IIStatusTerminatedWhereNew York
- Medicine recall TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL) Crystallization: Formation of crystals observed in product. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Atorvastatin Calcium 40 MG Tablet, MFG: Apotex Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportPennsylvaniathe one state its words name PublishedOct 22, 2014ClassClass IIStatusTerminatedWherePennsylvania
- Medicine recall Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset Class IIIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Vasotec (enalapril maleate) tablets Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert. Class IIIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Dipyridamole API cGMP Deviations: GYMA laboratories Inc. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Propranolol HCl cGMP Deviations: GYMA laboratories Inc. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clonidine Base Micronized, 55.8 Kg cGMP Deviations: GYMA laboratories Inc. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clonidine HCL, 97 Kg cGMP Deviations: GYMA laboratories Inc. Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Hydrocortisone Butyrate Cream 0.1% Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point Class IIIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 22, 2014ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Locoid (hydrocortisone butyrate 0.1%), Cream Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point Class IIIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 22, 2014ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC… Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration… Class IIFDA’s classOct 22, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 22, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Amiodarone HCl Injection, 450 mg/9 mL Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical… Class IIFDA’s classOct 15, 2014in FDA’s Enforcement Report3 statesnamed in where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereMontana, Oregon and Washington
- Medicine recall Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample. Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance. Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing. Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups Defective Container: Product leaks when inverted. Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133 Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall All sterile products within expiry Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended… Class IIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only,… Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates. Class IIIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months. Class IIIFDA’s classOct 15, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 15, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall CUBICIN (daptomycin for injection), 500 mg single-use vial Presence of Particulate Matter: Potential presence of glass particulate matter in the vials. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the… FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall All sterile drugs compounded between 2/21/14 and 2/24/14. Lack of Assurance of Sterility: All compounded products. Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNot namedno state, in where it went PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNo state named
- Medicine recall DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into… Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dianeal Low Calcium Presence of Particulate Matter: particulate matter was found during the manufacturing process. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000. Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd. Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement Report11 statesnamed in where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereFlorida, Illinois, Indiana, Louisiana, Maryland, Maine, New Jersey, Pennsylvania, South Carolina, Texas and Washington
- Medicine recall MOJO RISEN, 650 mg, 2 capsule per pouch Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement Report11 statesnamed in where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereFlorida, Illinois, Indiana, Louisiana, Maryland, Maine, New Jersey, Pennsylvania, South Carolina, Texas and Washington
- Medicine recall Zoledronic Acid Injection 5 mg per 100 mL Lack of Assurance of Sterility; leaking of premix bags Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets. Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-count bottle Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets. Class IIFDA’s classOct 8, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedOct 8, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158,… Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil. FDA Class I, its most serious class Class IFDA’s class (needs attention)Oct 8, 2014in FDA’s Enforcement Report11 statesnamed in where it went PublishedOct 8, 2014ClassClass IStatusTerminatedWhereFlorida, Illinois, Indiana, Louisiana, Maryland, Maine, New Jersey, Pennsylvania, South Carolina, Texas and Washington
- Medicine recall Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point Class IIIFDA’s classOct 1, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 1, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10 Carpuject Sterile Cartridge Units with… Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point. Class IIFDA’s classOct 1, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedOct 1, 2014ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.